Benefits of Statins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors for Patients with Peripheral Arterial Disease

Curr Vasc Pharmacol. 2023 Nov 30. doi: 10.2174/0115701611292747231129080204. Online ahead of print.NO ABSTRACTPMID:38037835 | DOI:10.2174/0115701611292747231129080204

Source: Current Vascular Pharmacology - December 1, 2023 Category: Drugs & Pharmacology Authors: Kosmas I Paraskevas Debabrata Mukherjee Theofanis T Papas Source Type: research